title: Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.
authors.affiliation: Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2584.
authors.forename: R C
authors.initials: RC
authors.lastname: MacDonell
authors.forename: D H
authors.initials: DH
authors.lastname: Van Buren
authors.forename: R E
authors.initials: RE
authors.lastname: Richie
authors.forename: H K
authors.initials: HK
authors.lastname: Johnson
authors.forename: W A
authors.initials: WA
authors.lastname: Nylander
authors.forename: J H
authors.initials: JH
authors.lastname: Helderman
authors.forename: C M
authors.initials: CM
authors.lastname: Ynares
authors.forename: L A
authors.initials: LA
authors.lastname: Trusler
authors.forename: W F
authors.initials: WF
authors.lastname: Green
authors.forename: D A
authors.initials: DA
authors.lastname: Crowe
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007223:Infant; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone